Please ensure Javascript is enabled for purposes of website accessibility

Frederick approves MedImmune expansion, road improvements

FREDERICK — The city of Frederick has finalized a loan package that will approve expansion of MedImmune’s Frederick biotech manufacturing plant and improve roads around the business.

The Frederick News-Post reports that the Board of Aldermen voted Thursday to approve a series of agreements between the company, the city and the State Highway Administration to reimburse the AstraZeneca-owned firm nearly $7 million to fund nearby road improvements.

The city of Frederick will reimburse the firm over 15 years for design and construction of an extra lane and additional off-ramps from state Route 180 to U.S. Highway 340.

City Economic Development Director Richard Griffin says the projects will improve traffic flow in the area.

MedImmune announced plans for a $200 million expansion late last year.